Malignant transformation of adenomyosis: literature review and meta-analysis

review OA: closed CC0 ⤵ 17 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-07

This review and meta-analysis examined risk factors and pathology of malignant transformation of adenomyosis, noting it occurs mostly in older patients and may be associated with other benign uterine diseases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This paper reviewed and meta-analyzed published research from PubMed on risk factors and pathology underlying malignant transformation of adenomyosis. The analysis found that most malignant transformations occur in elderly or postmenopausal patients, and that adenomyosis coexisting with uterine leiomyoma or benign endometrial hyperplasia (and other benign diseases) appears more prone to malignancy, although the evidence was not strong. The authors propose that malignant transformation may involve endometrial epithelium transitioning to monolayer tumor cells before progressing to cancer, but they note that the specific molecular mechanism remains unclear. They also emphasize major limitations, including low incidence, lack of large multi-center trials, and high heterogeneity leading to weak evidence for high-risk factors. This paper is centrally about endometriosis and adenomyosis — specifically adenomyosis malignant transformation risk factors and proposed pathological pathway.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 7,185 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose To review and analyze risk factors and the pathology of malignant transformation of adenomyosis.

Methods

In this paper, the relevant research on current risks factors and the pathology of malignant transformation of adenomyosis was reviewed and analyzed by metaanalysis. All studies included were retrieved from the PUBMED.

Results

Analysis of existing studies revealed that most malignant transformation of adenomyosis occurs in elderly or postmenopausal patients. Adenomyosis with uterine leiomyoma or benign endometrial hyperplasia and other benign diseases appears to be more prone to malignancy, but there is currently no strong evidence to confirm this finding.

Conclusions

At present, the malignant transformation of adenomyosis is thought to be due to its endometrial epithelium transition to monolayer tumor cells before malignant transformation, which eventually develops to varying degrees of cancer. However, the specific molecular mechanism of adenomyosis is not yet clear. Because of its low incidence of malignant transformation, lack of large-sample, multi-center clinical trials, and large heterogeneity of the existing research, the evidence based on the high-risk factors of malignant transformation of adenomyosis is weak. Similar content being viewed by others

References

Koike N, Tsunemi T, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Kobayashi H (2013) Pathogenesis and malignant transformation of adenomyosis (review). Oncol Rep 29:861–867 (Published online EpubMar (10.3892/or.2012.2184)) Taran FA, Stewart EA, Brucker S (2013) Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe und Frauenheilkunde 73:924–931 (Published online EpubSep (10.1055/s-0033-1350840)) Hong SC, Khoo CK (2016) An update on adenomyosis uteri. Gynecol Min Invas Ther 5:106–108. https://doi.org/10.1016/j.gmit.2015.08.003 Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA (2007) Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma. Int J Gynecol Pathol 26:278–283. https://doi.org/10.1097/01.pgp.0000235064.93182.ec Mori M, Furusawa A, Kino N, Uno M, Ozaki Y, Yasugi T (2015) Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis. J Obstet Gynaecol Res 41:324–328 (Published online EpubFeb 10.1111/jog.12513) Kazandi M, Zeybek B, Terek MC, Zekioglu O, Ozdemir N, Oztekin K (2010) Grade 2 endometrioid adenocarcinoma arising from adenomyosis of the uterus: report of a case. Eur J Gynaecol Oncol 31:719–721 Hsu MI, Chou SY, Lin SE, Liang SJ, Chiu HC, Hsu CS (2006) Very early stage adenocarcinoma arising from adenomyosis in the uterus. Taiwan J Obstet Gynecol 45:346–349 (Published online EpubDec (10.1016/s1028-4559(09)60258-8)) Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, Adachi S, Garcia-Sayre J, Ueda Y, Roman LD (2016) Tumor characteristics and survival outcome of endometrial cancer arising in adenomyosis: an exploratory analysis. Ann Surg Oncol 23:959–967 (Published online EpubMar (10.1245/s10434-015-4952-y)) Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA (2007) Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Annals of diagnostic pathology 11:252–257 (Published online epubaug (10.1016/j.anndiagpath.2006.08.011)) Koshiyama M, Okamoto T, Ueta M (2004) The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detect Prev 28:94–98. https://doi.org/10.1016/j.cdp.2003.12.008 Taneichi A, Fujiwara H, Takahashi Y, Takei Y, Machida S, Saga Y, Takahashi S, Suzuki M (2014) Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma. Int J Gynecol Cancer 24:1429–1433 (Published online EpubOct (10.1097/IGC.0000000000000243)) Genc M, Genc B, Cengiz H (2015) Adenomyosis and accompanying gynecological pathologies. Arch Gynecol Obstet 291:877–881 (Published online EpubApr (10.1007/s00404-014-3498-8)) Baba A, Yamazoe S, Dogru M, Ogawa M, Takamatsu K, Miyauchi J (2016) Clear cell adenocarcinoma arising from adenomyotic cyst: A case report and literature review. The journal of obstetrics and gynaecology research 42:217–223 (Published online EpubFeb (10.1111/jog.12866)) Lu B, Chen Q, Zhang X, Cheng L (2016) Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol 11:46 (Published online EpubJun 04 (10.1186/s13000-016-0496-0)) Izadi-Mood N, Samadi N, Sarmadi S, Eftekhar Z (2007) Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma. Arch Iran Med 10:258–260 (Published online EpubApr (07102/aim.0026)) Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman LD (2014) Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Ann Surg Oncol 21:4246–4255 (Published online EpubDec (10.1245/s10434-014-3880-6)) Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA (2000) Loss of heterozygosity in adenomyosis on hMSH2, hMLH1, p16Ink4 and GALT loci. International journal of molecular medicine 6:667–671 (Published online EpubDec) Jones RK, Searle RF, Bulmer JN (1998) Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod (Oxford, England) 13:3496–3502 (Published online EpubDec) Jichan N, Xishi L, Guo SW (2010) Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci 17:995–1005 (Published online EpubNov (10.1177/1933719110377118)) Sampson JA (1925) Endometrial carcinoma of the ovary arising in endometrial tissue of that organ. Arch Surg 10:1–72 Colman HI, Rosenthal AH (1959) Carcinoma developing in areas of adenomyosis. Obset Gynecol 14:342–348 Gizzo S, Patrelli TS, Dall’asta A, DI Gangi S, Giordano G, Migliavacca C, Monica M, Merisio C, Nardelli GB, Quaranta M, Noventa M, Berretta R (2016) Coexistence of adenomyosis and endometrioid endometrial cancer: role in surgical guidance and prognosis estimation. Oncol Lett 11(2):1213–1219 (Epub 2015 Dec 15) Author information Authors and Affiliations Contributions HY Data Collection, Manuscript writing. SZ Data Collection, Manuscript writing Corresponding author Ethics declarations Conflict of interest Hang Yuan declares that she has no conflict of interest. Shiqian Zhang declares that he has no conflict of interest. Ethical approval This article does not contain any studies with human participants or animals performed by any of the authors. Rights and permissions About this article Cite this article Yuan, H., Zhang, S. Malignant transformation of adenomyosis: literature review and meta-analysis. Arch Gynecol Obstet 299, 47–53 (2019). https://doi.org/10.1007/s00404-018-4991-2 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-018-4991-2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

mesh:D004715adenomyosis

MeSH descriptors

Adenomyosis Cell Transformation, Neoplastic Endometrial Hyperplasia Leiomyoma Uterine Neoplasms Adenomyosis Adult Aged Cell Transformation, Neoplastic Endometrial Hyperplasia Endometriosis Endometriosis Endometrium Endometrium Female Humans Incidence Leiomyoma Middle Aged Risk Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (18)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:19:25.021412+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK